Cantabio Pharmaceuticals Inc.

Common Stock SEC Reporting - Current
Verified Company Profile 9/07/2016
Contact Info
  • 1250 Oakmead Pkwy
  • Sunnyvale, CA 94303

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2016 10-Q
CIK 0001550518
Fiscal Year End 3/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 8741 - Management services
Business Status Development Stage Company a/o Mar 31, 2013
Incorporated In: DE, USA
Year of Inc. 2012
Employees 11 a/o Mar 31, 2013
Company Officers/Contacts
Gergely Toth CEO
Thomas Roger Sawyer COO
Simon Peace CFO
Company Directors
Simon Peace
Thomas Roger Sawyer
Gergely Toth
Company Notes
  • Formerly=Lion Consulting Group Inc until 10-2015
Service Providers
Accounting/Auditing Firm
Marcum LLP
750 Third Ave
11th Floor
New York, NY, 10017
United States

Legal Counsel
Sanders Ortoli Vaughn-Flam Rosenstadt LLP
501 Madison Avenue
14th Floor
New York, NY, 10022
United States

Investor Relations Firm
Russo Partners LLC
75 Ninth Avenue
New York, NY, 10011
United States

CTBO Security Details
Share Structure
Market Value1 $7,438,462 a/o Oct 27, 2016
Authorized Shares 250,000,000 a/o Jul 18, 2016
Outstanding Shares 26,805,270 a/o Jul 18, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 11,750,000 a/o Jul 18, 2016
Par Value Not Available
Transfer Agent(s)
Island Stock Transfer
Shareholders of Record 17 a/o Jul 18, 2016
Short Selling Data
Short Interest 11,963 (-72.69%)
Sep 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security